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Abstract
Background: Zinc plays important roles in maintaining normal function of the prostate and in
development of prostate malignancy. It has been demonstrated that prostate malignant epithelial
cells contain much less cellular zinc than the surrounding normal epithelial cells. However, the
pathway(s) which leads to lower zinc accumulation in malignant prostate epithelial cells is poorly
understood. In this study, the zinc homeostatic features of two human prostate epithelial cell lines
(non-tumorigenic, RWPE1, and tumorigenic, RWPE2) were investigated. Effects of over-expression
of ZIP1 in RWPE2 on cell proliferation and apoptosis were also studied.
Results: RWPE2 accumulated less intracellular zinc than RWPE1 due to the decreased zinc uptake
activity. The mRNA expression of ZIP1 and ZIP3 in RWPE1 and RWPE2 was comparable.
However, the protein expression of ZIP1 in RWPE2 was lower than that in RWPE1. ZIP3 was
detected in a lysosomal compartment of RWPE2 while no ZIP3 was detected in the same
compartment of RWPE1. Over-expression of ZIP1 in RWPE2 resulted in an elevation of
intracellular zinc concentration and suppression of cell growth of RWPE2 due to the increased
apoptosis.
Conclusion: These findings suggest that tumorigenic prostate epithelial cells accumulated less
intracellular zinc than non-tumorigenic prostate epithelial cells. The reduction in capacity for
accumulation of intracellular zinc in tumorigenic prostate epithelial cells may be caused by the
decrease in the ZIP1 protein expression and the intracellular redistribution of ZIP3 in RWPE2.
RWPE1 and RWPE2 are excellent cellular models to study the association of intracellular zinc levels
with prostate cancer progression.
Background
It is well known that normal human prostate glands accu-
mulate almost 10-fold higher zinc as compared to other
soft tissues, such as liver and kidney [1,2]. Accumulation
of cellular zinc and secretion of zinc into the prostatic
fluid in prostate glands are essential functions of the pros-
tate secretory epithelial cell [3]. Additionally, low zinc
concentration in seminal plasma may affect the mobility
of sperm which can result in infertility in men [4-6]. The
glandular epithelial cells in the dorsolateral lobe of the
prostate accumulate the highest levels of intracellular zinc
[3,7]. This is also the area where most prostate cancers
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occur. This observation strongly suggests that zinc has an
important role in prostate cancer development and/or
progression. Studies have indicated that the intracellular
zinc levels in malignant prostate epithelial cells are dra-
matically decreased [8,9]. This contrasts with benign pro-
static hyperplasia in which the epithelial cells accumulate
normal or higher levels of zinc [8,9]. The reduction of
intracellular zinc concentrations in prostate epithelial
cells may promote prostate cancer initiation and/or pro-
gression via cell cycle arrest, programmed cell death,
necrosis, or oxidative stress [2,10-14]. Although zinc is an
important factor in prostate biology and pathology, the
exact roles of zinc and its homeostatic regulation in the
normal and malignant prostate glands are not under-
stood.
Recent advances in the study of molecules involved in
intracellular zinc homeostasis, such as zinc transporters,
have given us a hope to dissect the molecular mechanisms
of how the high zinc levels are maintained in prostate epi-
thelial cells under normal conditions and how the pros-
tate epithelial cells become "zinc deficient" under
malignant conditions. Two families of zinc-transporter
proteins, ZnT (Zinc Transporter) and ZIP (ZRT1, IRT1-like
protein) have been identified in mice and human [15,16].
The ZnT proteins, which are the members of the CDF fam-
ily (cation diffusion facilitator), appear to function either
by transporting zinc out of the cell or by sequestering zinc
into intracellular compartments [16]. In contrast, the ZIP
proteins appear to function in uptake of extracellular or in
release of stored zinc into the cytoplasm [15]. At present,
24 zinc transporters (10 ZnT and 14 ZIP proteins) have
been identified through genomic sequence analysis in
mammals. Thirteen of them have been functionally char-
acterized [17-28]. These studies have indicated that zinc
transporters act in tissue, cell type, and organelle specific
manner with some functional redundancy. These special-
ized zinc transporters maintain intracellular zinc concen-
trations in a narrow physiologic range.
The activities of zinc transporters are regulated by extracel-
lular zinc concentrations via transcription, translation,
and protein trafficking. For example, in zinc-replete con-
ditions, the expression of ZnT1 mRNA and protein is up-
regulated [29]. Meanwhile, ZIP1 and ZIP3 are rapidly
internalized from the plasma membrane to intracellular
compartments accompanied by the redistributions of the
ZnT4 and ZnT6 proteins from their Golgi apparatus to the
periphery of the cell [22,30]. These zinc-induced regula-
tions via either decreasing zinc influx and/or increasing
zinc efflux maintain the cellular zinc concentration at the
level adequate for their physiologic targets while minimiz-
ing the toxicity of zinc excess.
Given the importance of zinc in the normal function of
the prostate and in the development and/or progression
of prostate cancer, we investigated the effects of extracellu-
lar zinc on zinc accumulation and on mRNA and protein
expression of zinc transporters in two cultured prostate
epithelial cell lines, RWPE1 and RWPE2. The RWPE1 cell
line was immortalized with human papillomavirus 18
from histological normal prostate epithelial cells and the
RWPE2 cell line was derived from RWPE1 by transform-
ing the cells with Kirsten murine sarcoma virus (Ki-MuSV)
[31]. RWPE1 and RWPE2 have retained normal epithelial
cell morphology and both cell lines express cytokeratins 8
and 18, which are the markers for the prostate intermedi-
ate epithelial cell type with proliferative ability. Both cell
lines are hormone sensitive and are positive for the andro-
gen receptor expression. When cultured in the medium
containing 5 nM mibolerone, both cell lines expressed
PSA with higher levels detected in RWPE2. The RWPE2
cells can grow in soft agar in vitro and develop tumors in
nude mice whereas the RWPE1 cells can not. So, RWPE1
and RWPE2 essentially share the same genotype differing
only in their tumorigenic status [31]. In this study, we
found that the capacity for zinc accumulation was
decreased in RWPE2 because of the aberrant protein
expression and cellular localization of zinc uptake pro-
teins, ZIP1 and ZIP3. Over-expression of ZIP1 in RWPE2
increased intracellular zinc levels and suppressed cell
growth through apoptosis.
Results
Decreased total cell-associated zinc level in tumorigenic 
prostate epithelial cells
It has been demonstrated that prostate cancer tissues con-
tain less cellular zinc compared to the surrounding non-
cancerous tissues [8,9]. In order to elucidate the molecular
basis underlying this clinical finding, we studied the zinc
homeostatic features of two existing prostate epithelial
cell lines, RWPE1, a non-tumorigenic prostate epithelial
cell line, and RWPE2, its tumorigenic counterpart. We first
examined the total cell-associated zinc levels in RWPE1
and RWPE2 by their ability to accumulate intracellular
zinc while cultured in zinc repleted conditions. As shown
in Fig. 1a, the total cell-associated zinc levels in RWPE1
and RWPE2 were not significantly different when both
cell lines were cultured in the K-SFM supplemented with
human recombinant epidermal growth factor and bovine
pituitary extract, which contained about 0.7 µM zinc ions.
However, the total cell-associated zinc level in RWPE2 was
greatly reduced (39% reduction) compared to that in
RWPE1 when cells were cultured in the medium contain-
ing 75 µM ZnSO4 at 37°C for 48 hours. The reduced abil-
ity to accumulate intracellular zinc in RWPE2 was further
confirmed by a 65Zn accumulation analysis. The accumu-
lation of 65Zn (0.05 µM) over a period of 60 minutes was
performed in a zinc uptake buffer and the γ counts were
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measured. Consistent with the results obtained with total
cell-associated zinc measurement, RWPE2 only accumu-
lated 52% of 65Zn that was accumulated in RWPE1 (Fig.
1b). These results suggest that the ability to accumulate
intracellular zinc is suppressed in RWPE2.
Reduced 65Zn uptake in RWPE2
We hypothesized that the zinc uptake system may be dis-
rupted in RWPE2 which led to a reduction of intracellular
zinc accumulation. Therefore, we examined the zinc
uptake activities in RWPE1 and RWPE2 by determining
the initial rates of 65Zn uptake. As shown in Fig. 2, RWPE1
accumulated zinc at an initial rate of 2.7 pmol/min/106
cells, whereas in RWPE2, that rate was decreased to 1.8
pmol/min/106, a 33% reduction in zinc uptake activity.
Taken together, these results strongly suggest that the
decreased intracellular zinc accumulation in RWPE2 may
be due to the incompetence of zinc uptake system of these
cells.
Expression of zinc transporters in RWPE1 and RWPE2
To determine the molecular basis for the incompetence of
the zinc uptake system in RWPE2, we first examined the
mRNA expression profiles of zinc uptake transporters in
RWPE1 and RWPE2. Total RNA was purified from RWPE1
and RWPE2 treated with either 0 or 75 µM ZnSO4 for 48
hours. The mRNA expression levels of four known zinc
uptake proteins, ZIP1-4, were determined using a real-
time quantitative RT-PCR analysis with TaqMan probes
specific to these genes (Applied Biosystems). Although the
abundance of the ZIP3 transcripts was about 20% and
40% less than that of ZIP1 in RWPE1 and RWPE2, respec-
tively, the mRNA expression levels of ZIP1 and ZIP3 were
similar between RWPE1 and RWPE2 (p > 0.05) (Fig. 3). In
addition, both ZIP1 and ZIP3 mRNA expression was not
affected by zinc treatment (p > 0.05, Fig. 3). Taken
together, these results suggest that the discrepancy in zinc
accumulation between RWPE1 and RWPE2 does not
result from the transcriptional activities of the ZIP1 and
ZIP3 genes. Using RT-PCR with TaqMan probes, the ZIP2
mRNA was barely detectable and no ZIP4 mRNA was
detected (data not shown) in RWPE1 and RWPE2.
Intracellular localization of ZIP1 and ZIP3 in RWPE1 and 
RWPE2
The disrupted zinc homeostasis in RWPE2 may be caused
by the changes in protein trafficking of zinc transporters.
To test this hypothesis, expression and localization of
ZIP1, ZIP3, ZNT1-2, and ZNT4-7 in RWPE1 and RWPE2
were examined by immunofluorescence microscopy. No
detectable difference in protein distributions and intensi-
ties of ZNT1-2 and ZNT4-7 between RWPE1 and RWPE2
were observed (data not shown). The cellular distribution
of ZIP1, which was localized on the cytoplasmic mem-
brane as well as intracellular vesicles, is similar between
RWPE1 and RWPE2 (Fig. 4a, panels A and C). Zinc treat-
Cellular zinc accumulation in RWPE1 and RWPE2Figure 1
Cellular zinc accumulation in RWPE1 and RWPE2. a. Total 
cell-associated zinc contents. RWPE1 and RWPE2 were 
grown to ~50% confluence and treated with 0 or 75 µM 
ZnSO4 at 37°C for 48 hours. Cells were harvested and 
assayed for total cell-associated zinc contents by inductively 
coupled plasma-atomic emission spectrometry. Values are 
the means ± SE, n = 3 (three independent experiments). b. 
65Zn accumulation. RWPE1 and RWPE2 were grown to 
~70% confluence and harvested. Zinc accumulation was 
assayed with 0.05 µM 65ZnCl2 from 0 to 60 minutes. Values 
are the means ± SE, n = 3 (one representative experiment of 
three with similar results).
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ment (50 µM ZnSO4 at 37°C for 2 hours) has little effect
on the cellular localization of ZIP1 in RWPE1 (Fig. 4a,
panel B) and RWPE2 (Fig. 4a, panel D). The ZIP3 protein
was localized throughout RWPE1 (Fig. 4a, panel E). It was
intriguing that numerous strong stained particles were
detected in RWPE2 with the anti-ZIP3 antibody in addi-
tion to the vesicle staining observed in RWPE1 (Fig. 4a,
panel G). The distribution pattern of these fluorescent
particles resembles the localization of the lysosomal com-
partment [32]. To conform the localization of the punc-
tate staining of ZIP3 in RWPE2, we compared the cellular
localizations of ZIP3 and LAMP1, a lysosome-associated
membrane protein [33], in RWPE2 by immunofluores-
cent co-localization assay. As shown in Fig. 4b, most
punctate staining of ZIP3 (Fig. 4b, panel A) was overlap-
ping with that of LAMP1 (Fig. 4b, Panel C) in RWPE2,
strongly suggesting that the ZIP3 protein was compart-
mentalized in lysosomes in these cells. Furthermore, the
cellular localization of ZIP3 was not affected by zinc treat-
ment (50 µM ZnSO4 at 37°C for 2 hours) in RWPE1 and
RWPE2 (Fig. 4a, panel F and H, respectively).
Decrease in the protein expression of ZIP1 in RWPE2
It has been demonstrated lately that the ZIP1 protein
expression was down-regulated in the malignant prostate
tissues [34]. This prompted us to examine and compare
the protein expression levels of ZIP1 as well as ZIP3 in
RWPE1 and RWPE2 by western blot analyses. We found
that the ZIP1 protein expression was down-regulated
~36% in RWPE2 compared to that in RWPE1 (Fig. 5a
&5b) whereas the protein expression of ZIP3 was compa-
rable between RWPE1 and RWPE2 (data not shown).
Moreover, the expression of the ZIP1 protein was regu-
lated by extracellular zinc. As shown in Fig. 5c, the levels
of ZIP1 dramatically decreased in the RWPE1 cells treated
with 25 µM or 50 µM ZnSO4 for 24 hours as compared to
these treated with 0 µM ZnSO4. Zinc had no effect on the
protein expression levels of ZIP3 in RWPE1 and RWPE2
(data not shown). Taken together, the results suggested
that the regulatory mechanism of ZIP1 and ZIP3 are dis-
tinctive in prostate epithelial cells.
Generation of RWPE2 cell lines carrying vector control or 
ZIP1-Myc plasmid
Our studies in 65zinc uptake and immunofluorescent
assays suggested that the low accumulation of intracellu-
lar zinc in RWPE2 may partially be due to the down-regu-
lation of zinc uptake transporter protein expression (Fig.
5). We sought to over-express the ZIP1 protein in RWPE2
to examine the effects of elevated intracellular zinc levels
on cell proliferation and apoptosis. RWPE2 stably trans-
fected with a vector or a ZIP1-Myc expressing plasmid, in
which the Myc epitope was tagged at the C-terminal end
65Zn uptake in RWPE1 and RWPE2Figure 2
65Zn uptake in RWPE1 and RWPE2. RWPE1 and RWPE2 
were grown to ~70% confluence and harvested. 65Zn uptake 
was assayed with 0.05 µM 65ZnCl2 from 0 to 60 seconds. Val-
ues are the means ± SE, n = 3 (one representative experi-
ment of three with similar results).
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mRNA expression of zinc uptake transporters in RWPE1 and RWPE2Figure 3
mRNA expression of zinc uptake transporters in RWPE1 and 
RWPE2. RWPE1 and RWPE2 were grown to ~50% conflu-
ence and treated with 0 or 75 µM ZnSO4 at 37°C for 48 
hours. Cells were harvested and total RNA was isolated. 
Gene expression of ZIP1 and ZIP3 were measured by quanti-
tative RT-PCR with TaqMan probes and normalized to the β-
actin expression. The gene expression levels are presented 
as copy numbers/104 β-actin transcripts. Values are the 
means ± SE, n = 6 (two independent experiments).
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Subcellular localization of ZIP1 and ZIP3 in RWPE1 and RWPE2Figure 4
Subcellular localization of ZIP1 and ZIP3 in RWPE1 and RWPE2. a. Localization of  ZIP1 and ZIP3. RWPE1 and RWPE2 were 
seeded at ~50% confluence in a 4-well slide chamber and cultured at 37°C for 48 hours. Cells were then treated with 0 or 50 
µM ZnSO4 at 37°C for 2 hours before immunofluorescent staining. The endogenous ZIP1 and ZIP3 proteins in RWPE1 and 
RWPE2 were detected by a chicken anti-ZIP1 antibody and a rabbit anti-ZIP3 antibody, respectively. An Alexa 488-conjugated 
goat anti-chicken (ZIP1) or anti-rabbit (ZIP3) antibody were used as secondary antibodies for the photomicrographs. Arrows 
indicate the plasma membrane localization of ZIP1. b. Localization of ZIP3 and LAMP1 in RWPE2. RWPE2 were seeded at 
~50% confluence in a 4-well slide chamber and cultured at 37°C for 48 hours. Cells were fixed, permeablized, and stained as 
described in the Methods. The green (ZIP3, panel A) and red (LAMP1, panel B) florescent images were merged to indicate the 
area of overlap (panel C), which is shown in yellow.
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of the human ZIP1 protein, were established. The levels of
the endogenous ZIP1 as well as the ZIP-Myc transcripts
were examined by quantitative RT-PCR with a TaqMan
probe specific for ZIP1 (Applied Biosystems). As shown in
Fig. 6a, the expression of ZIP1 mRNA was 2.5- and 4.5-
fold higher in the ZIP1-Myc expressing RWPE2 Clone A
and Clone B, respectively, than that in the control RWPE2.
Zinc treatment (25 µM ZnSO4 for 24 hours) led to a fur-
ther increase (~2-fold) of ZIP1-Myc expression in the
ZIP1-Myc expressing RWPE2 cells due to the stimulation
of the CMV promoter which controls the transcription of
the ZIP1-Myc gene by zinc (Fig. 6a and [25]). An immun-
ofluorescent staining assay using a mouse anti-Myc anti-
body indicated that the ZIP1-Myc fusion protein was
expressed in the ZIP1-Myc stably transfected RWPE2 cells
(Fig. 6b). The staining results also indicated that the ZIP1-
Myc fusion protein was distributed normally as the
endogenous ZIP1 protein (Fig. 4a, panel A).
It has been demonstrated that the expression of ZNT1
mRNA is up-regulated by elevated intracellular zinc con-
centrations [29,35]. Thus, we used ZNT1 mRNA expres-
sion levels to confirm that over-expression of ZIP1-Myc in
RWPE2 resulted in increased cellular zinc levels in these
cells. The ZNT1 mRNA was measured by quantitative RT-
PCR with a TaqMan probe specific for ZNT1 (Applied Bio-
systems). As shown in Figure 6c, the ZNT1 expression lev-
els in the ZIP1-Myc expressing RWPE2 were about 1.8-
fold (Clone A) and 1.4-fold (Clone B) higher than that in
the vector transfected RWPE2, respectively, under the nor-
mal culture conditions. In addition, the expression of
ZNT1 in both vector and ZIP1-Myc transfected RWPE2
was up-regulated by zinc (Fig. 6c). Taken together, these
results suggest that over-expression of the ZIP1-Myc pro-
tein in RWPE2 results in an increase of intracellular labile
zinc level which was sensed by the ZNT1 gene.
Inhibition of cell growth by over-expression of ZIP1 in 
RWPE2
The mortality of prostate cancer is highly associated with
tumor cell proliferation and apoptosis. The faster cell pro-
liferation and/or lesser apoptosis the tumor is, the higher
mortality it is. Therefore, the pathways involved in cell
proliferation and apoptosis have been focused on for
potential intervention of prostate cancer progression. In
order to determine the effects of increased intracellular
zinc in the ZIP1-Myc expressing RWPE2 on cell growth,
we performed an in vitro cell growth assay with or without
zinc (0 or 25 µM ZnSO4) added into the culture medium.
We used 0 µM ZnSO4 treatment to represent a normal cul-
ture condition and 25 µM zinc to mimic the zinc supple-
mental condition. The normal human serum zinc values
are about 9–16 µM [36].
Expression of the ZIP1 protein in RWPE1 and RWPE2Figure 5
Expression of the ZIP1 protein in RWPE1 and RWPE2. a. 
Detection of the ZIP1 protein. Western blot containing 50 
µg of protein extracts isolated from RWPE1 and RWPE2 
cells were probed with a chicken anti-ZIP1 antibody followed 
by a peroxidase-conjugated secondary anti-chicken antibody. 
ZIP1 was visualized using an ECL kit (Amersham Bio-
sciences). The detection of GRP78 on the same western blot 
was served as loading control. The protein markers (Bio-
Rad) are shown. b. Quantitation of the expression level of 
the ZIP1 protein. The ZIP1 and GRP78 signals from the 
western blot (Fig. 5a) were quantified by an Alpha Innotech 
Gel Documentation System (Alpha Innotech). The expres-
sion of ZIP1 was normalized by the expression of GRP78. c. 
Regulation of the ZIP1 protein expression by zinc. RWPE1 
cells were grown for 24 hours and treated with 0, 25, or 50 
µM ZnSO4 for 24 hours. Cell lysate was prepared and ana-
lyzed by western blot assay. The ZIP1 and GRP78 proteins 
were detected as described as above.
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Over-expression of ZIP1-Myc in RWPE2Figur  6
Over-expression of ZIP1-Myc in RWPE2. RWPE2 was stably transfected with an empty vector or a ZIP1-myc expressing plas-
mid. a. Expression of the ZIP1-Myc mRNA in two stably transfected RWPE2 cell lines. Vector or ZIP-Myc transfected (Clone 
A and Clone B) RWPE2 were seeded at ~50% confluence and 0 or 25 µM ZnSO4 was added into the medium after 24 hours 
incubation. Cells were then incubated at 37°C for another 24 hours and total RNA was isolated. The endogenous ZIP1 as well 
as ZIP1-Myc mRNA were measured by quantitative RT-PCR with a TaqMan probe specific for ZIP1. The expression of ZIP1 
mRNA was normalized to the β-actin mRNA expression. Values are the means ± SD of three experiments. b. Expression and 
localization of ZIP1-Myc in stably transfected RWPE2. Vector and ZIP1-Myc transfected RWPE2 were seeded at ~25% conflu-
ence and cultured at 37°C for 48 hours. ZIP1-Myc was detected by a mouse anti-Myc antibody (panel B). Arrow indicates the 
plasma membrane localization of ZIP1-Myc. The Myc staining of RWPE2 stably transfected with the vector control is shown in 
panel A. c. Expression of ZNT1 mRNA in stably transfected RWPE2. Vector or ZIP1-Myc expressing (Clone A and Clone B) 
RWPE2 were seeded at ~50% confluence and 0 or 25 µM ZnSO4 was added into the medium after 24 hours incubation. Cells 
were then incubated at 37°C for another 24 hours and total RNA was isolated. The endogenous ZNT1 mRNA was measured 
by quantitative RT-PCR with a TaqMan probe specific for ZNT1. The expression of ZNT1 was normalized to the β-actin 
expression. Values are the means ± SD of three experiments.
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The growth of the ZIP1-Myc expressing RWPE2 and their
vector control were monitored for 12 days at 37°C in the
presence of 0 or 25 µM ZnSO4 in the culture medium. The
culture medium was changed at days 3, 6, and 9 after cells
were seeded. Cells were harvested and cell numbers were
determined at days 6, 9, and 12 after plating. As shown in
Fig. 7, the growth of the ZIP1-Myc expressing RWPE2 was
37% (Clone A) and 43% (Clone B) slower than their vec-
tor control (p < 0.01). Zinc treatment (25 µM ZnSO4) did
not further inhibit the growth of the ZIP1-Myc expressing
RWPE2. In addition, there was no effect of extracellular
zinc (25 µM ZnSO4) on the growth of the vector control.
Increased apoptosis in RWPE2 over-expressing ZIP1
To address pathways that led to slower growth of ZIP1
over-expressing RWPE2, we examined the cell prolifera-
tion rate by cell cycle progression and programmed cell
death by caspase 3 activity. We found that over-expression
of ZIP1 in RWPE2 did not affect cell cycle progression of
RWPE2 (Fig 8a). Although the mean percentage of G2/M
of RWPE2 over-expressing ZIP1 (clone A) was lower than
that of the vector control, it was not statistically significant
(p > 0.05). We then examined the apoptotic death of vec-
tor or ZIP1 over-expressing RWPE2 by analyzing caspase 3
enzymatic activity. Caspase 3 is one of the intracellular
cysteine proteases that are synthesized as zymogens and
then proteolytically activated early in the course of apop-
tosis [37]. Vector control and ZIP1 over-expressing
RWPE2 were treated with TRAIL (tumor necrosis factor a-
related apoptosis-inducing ligand) at 37°C for 6 hours
and the caspase 3 activities were measured as described in
the Methods. TRAIL is an apoptotic inducing protein that
binds to its receptors (DR4 and DR5) to transduce an
apoptotic signal to the downstream apoptotic pathway.
After 6 hours TRAIL treatment, control RWPE2 cells were
resistant to the low concentration of TRAIL (10 ng/ml, Fig.
8b). This result is consistent with the observation [38] that
human prostate cancer cell lines including PC3, DU145,
and LNCaP were not sensitive to the TRAIL treatment.
However, over-expression of ZIP1 in RWPE2 cells made
cells (Clone A & B) sensitive to the TRAIL-induced apop-
tosis (~90% increase, Fig. 8b), suggesting that an increase
of intracellular zinc concentration via zinc uptake protein
in malignant prostate epithelial cells may be useful for the
treatment of prostate cancer.
Discussion
The uniqueness of the normal mammalian prostate epi-
thelial cells is their ability to accumulate high cellular
zinc. However, malignant prostate epithelial cells lose this
function [8,9,34]. To better understand the role of zinc in
the development and progression of prostate cancer, we
investigated and compared the features of a non-tumori-
genic and a tumorigenic human prostate epithelial cell
lines in aspects of zinc accumulation, zinc uptake, zinc
transporter expression profiles, and functional conse-
quences of over-expression of a major prostate zinc
uptake protein, ZIP1. In this study, we used two existing
cellular models, the non-tumorigenic human prostate epi-
thelial cells, RWPE1, and its tumorigenic counterpart,
RWPE2, because both cell lines essentially share the same
genetic background. We demonstrated that both RWPE1
and RWPE2 possess the ability to accumulate zinc when
zinc was added into the culture medium. However, the
levels of the accumulated zinc in RWPE2 were 39% and
48% lower than that of RWPE1 in a total cell-associated
zinc assay and a 65Zn accumulation assay, respectively.
These findings confirmed the clinic observation that the
prostate cancer cells contained less cellular zinc than the
normal epithelial cells in the surrounding areas, indicat-
ing that the function of zinc accumulation in malignant
prostate epithelial cells is impaired during tumorigensis
[1,8,9,34]. Our results also demonstrated that RWPE1 and
RWPE2 are excellent in vitro cellular models for studying
intracellular zinc homeostasis of prostate epithelial cells
under the normal and malignant conditions.
The tight homeostatic control of cellular zinc is largely
accomplished by the regulation of zinc influx and efflux
systems. Thus, less zinc accumulation in malignant pros-
tate epithelial cells may result from reduced zinc uptake
and/or increased zinc export. In this study, we conclude
Effect of over-expression of ZIP1-Myc on RWPE2 cell growthFigure 7
Effect of over-expression of ZIP1-Myc on RWPE2 cell 
growth. Vector or ZIP1-Myc expressing (Clone A and Clone 
B) RWPE2 were plated at a density of 20,000 per well in 12-
well plates for 24 hours and then 0 or 25 µM ZnSO4 was 
added into the medium. Medium was changed at days 3, 6 
and 9 after plating. Cells were harvested and cell numbers 
were determined at days 6, 9, and 12 after plating. Values are 
the means ± SD of three experiments.
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that the zinc uptake system rather than the zinc efflux sys-
tem of RWPE2 is impaired during tumorigensis. This con-
clusion is based on several independent observations.
First, we found that the initial rate of zinc uptake of
RWPE2 was decreased 33% compared to its non-tumori-
genic counterpart (Fig. 2). The level of the reduction in
zinc uptake of RWPE2 is in agreement with that of the
reduction in total cell-associated zinc accumulation. Sec-
ond, the protein expression level of ZIP1, a major zinc
uptake protein in prostate epithelial cells [39], was down-
regulated in RWPE2 (Fig. 5). This result is consistent with
the observation that the ZIP1 protein was down-regulated
and cellular zinc was depleted during prostate cancer pro-
gression in the clinical specimens of human prostate can-
cer tissues [34]. Third, perhaps the significant discovery is
that the ZIP3 protein may be subjected to degradation in
RWPE2 as ZIP3 was detected in a lysosomal compartment
(Fig. 4). Finally, we found no evidence showing that the
regulations of transcription, translation, and protein traf-
ficking of the ZNT genes including ZNT1-2 and ZNT4-7
were disrupted in RWPE2 (data not shown).
ZIP1 and ZIP3 have been demonstrated to be involved in
translocation of extracellular zinc into a variety of cell
types [24,26,30,39,40]. Inhibition of the activities of ZIP1
and ZIP3 leads to reduction of zinc uptake [24,26,39,40].
Our study suggests that the inhibitory mechanisms for
ZIP1 and ZIP3 transport activities may not be the same in
prostate epithelial cells. We demonstrate that the regula-
tory mechanism for the ZIP1 activity is exerted at the
translational level in prostate epithelial cells. Higher cellu-
lar zinc concentrations or tumorigenic state of prostate
epithelial cells decreased protein synthesis of ZIP1
whereas no effect was detected on the expression of
mRNA and the cellular localization of ZIP1. On the other
hand, the activity of ZIP3 was mainly regulated by the
tumorigenic state of prostate epithelial cells. In the tumor-
igenic prostate epithelial cells (RWPE2), ZIP3 was com-
partmentalized to the lysosome, where we speculate ZIP3
is subjected to degradation. In addition, zinc has no
effects on the mRNA and protein expression and cellular
localization of ZIP3 in prostate epithelial cells. The
domains mediating the regulations of protein expression
and protein trafficking of ZIP1 and ZIP3 are not clear. Fur-
ther studies are needed to determine these domains in
ZIP1 and ZIP3 and their regulatory mechanisms.
Reduction in the protein expression of ZIP1 observed in
RWPE2 led us to investigate the effects of over-expression
of ZIP1 in RWPE2 on cellular zinc accumulation, cell
growth, cell proliferation, and apoptosis. We demonstrate
that over-expression of ZIP1 in RWPE2 increased intracel-
lular zinc concentrations and inhibited cell growth in
both zinc-adequate and excess conditions. We also show
that the slower cell growth of ZIP1 over-expressing
Effect of over-expression of ZIP1-Myc on RWPE2 cell cycle progressi n and apopt sisFigu  8
Effect of over-expression of ZIP1-Myc on RWPE2 cell cycle 
progression and apoptosis. a. Effect of over-expression of 
ZIP1 on cell cycle. Vector or ZIP1-Myc expressing RWPE2 
cells were plated and grown for 24 hours. Cells were har-
vested and counted. 2 × 106 cells were ethanol fixed and 
processed for DNA staining with propidium Iodine. Cells 
were run on a FACS SCAN (BD Dickenson) with a 488 nm 
argon laser light source. 10,000 events were counted per 
sample. Values are the means ± SD of one representative 
experiment of two with similar results. b. Effect of over-
expression of ZIP1 on apoptosis. 2 × 106 vector or ZIP1-Myc 
expressing RWPE2 cells were plated in 100 mm plates and 
grown for 24 hours. Cells were treated with TRAIL (10 ng/
ml) at 37°C for 6 hours. Cells were harvested by trypsiniza-
tion. Caspase 3 activity was determined according to the 
manufacture's instructions (Clontech ApoAlert Caspase 
Colorimetric Assay Kit). Values are means ± SD of one rep-
resentative experiment of two with similar results.
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RWPE2 resulted from increased apoptosis in these cells.
The mechanism(s) underlying the enhanced sensitivity of
ZIP1-Myc over-expressing RWPE2 to TRAIL which led to
the activation of caspase 3 have yet to be identified. A
wide-range of apoptotic associated proteins which have
been demonstrated to play important roles in regulation
of TRAIL-mediated apoptosis are the primary targets for
the future study. These include 1) the death receptors
(DR4 and DR5) and the decoy receptors (DcR1, DcR2,
and OPG) expressed on the surface of ZIP1-Myc over-
expressing RWPE2; 2) the expression of NF-kappaB, Bax/
Bak, Bcl-2/Bcl-xL, and p53 in ZIP1-Myc over-expressing
RWPE2.
Conclusion
RWPE1 and RWPE2 cell lines are excellent cellular models
to study the association of intracellular zinc levels with
prostate cancer progression in vitro. Tumorigenic prostate
epithelial cells (RWPE2) accumulate less intracellular zinc
compared to the non-tumorigenic counterpart. The reduc-
tion in capacity for accumulation of cellular zinc in tum-
origenic prostate epithelial cells may be caused by the
decrease of ZIP1 expression and the redistribution of
ZIP3. The observation that increasing cellular zinc level by
over-expression of the zinc uptake protein, ZIP1, inhibits
tumorigenic prostate epithelial cell growth through apop-
tosis may provide a basis for a potential therapeutic strat-
egy for prostate cancer.
Methods
Cell culture and generation of stable cell lines
Human prostate epithelial cell lines (RWPE1 and RWPE2)
were purchased from American Tissue Collection Center
(ATCC) and were maintained in the Keratinocyte-serum
free medium (K-SFM) containing 5 ng/ml human recom-
binant epithelial growth factor (hrEGF), 0.05 mg/ml
bovine pituitary extract (Invitrogen), 100 U/ml Penicillin
G, and 100 µg/ml Streptomycin. The zinc contents for the
Keratinocyte-Serum Free medium with supplements were
about 0.7 µM determined by a Vista AX Simultaneous
ICP-AES (Varian). Both RWPE1 and RWPE2 grew adher-
ently in tissue culture. The ZIP1-Myc expressing cell line
and vector control cell line were generated by transfecting
pcDNA3.1/ZIP1-Myc or pcDNA3.1/Myc-His (Invitrogen)
into RWPE2 using LipofectAMINE plus kit (Invitrogen).
The stable cell lines were selected by culturing the cells in
the medium containing 400 µg/ml of G418 (Invitrogen).
Plasmid construction
The human EST clone (BI820953) containing the ZIP1
cDNA sequence was purchased from ATCC. The ZIP1
open reading frame (ORF) sequence lacking a stop codon
was amplified using a forward primer with a HindIII site
incorporated 11 base pairs upstream of the methionine
codon (5'-TCACTGAAGCTTCCAGAAGCATC-3') and a
reverse primer with a XhoI site incorporated in the stop
codon (5'-GAAGCCCTCGAGATTTGGATG-3'). The PCR
product was purified, digested with HindIII and XhoI
restriction enzymes, and inserted into the respective
enzyme sites of a mammalian expression vector,
pcDNA3.1/Myc/His, version B (Invitrogen). The resulting
plasmid pcDNA3.1/ZIP1-Myc was sequenced and used
for generation of a stable RWPE2 cell line expressing ZIP1-
Myc.
Measurement of total cell-associated zinc contents
RWPE1 and RWPE2 were seeded into 100-mm culture
plates at 2 × 106 cells per plate. Cells were treated with 0
or 75 µM ZnSO4 at 37°C for 48 hours after cells reached
to ~50% confluence. Cells were then harvested and
washed four times with 1× PBS, pH 7.4. Cell numbers
were determined by measuring the absorbance of cell sus-
pensions at OD600 nm (A600) and converting to cell
number based on a standard curve. The total cell-associ-
ated zinc in RWPE1 and RWPE2 was then measured by a
Vista AX Simultaneous ICP-AES (Varian) using nitric acid
digestion method [10].
Zn uptake and accumulation assays
RWPE1 and RWPE2 were grown in T-150 flasks for 72
hours (~70% confluence). Cells were treated with 1×
trypsin (Invitrogen) and neutralized with DMEM contain-
ing 10% FBS. Cells were then harvested by centrifugation
and washed once in cold 1× PBS, pH 7.4, and once in cold
uptake buffer (15 mM HEPES, 100 mM glucose, 150 mM
KCl, pH 7.0) [25]. Cells were resuspended in the uptake
buffer and cell numbers were determined by the standard
curve method. Tubes containing 3 × 105 cells per tube
(150 µl in total volume) were placed in a shaking incuba-
tor and incubated at 37°C for 10 minutes. Then an equal
volume of pre-warmed uptake buffer containing 15 pmol
65ZnCl2/150 µl (Oak Ridge National Laboratory, Oak
Ridge, TN) was added and incubated for the indicated
time points. Reactions were stopped by adding an equal
volume of ice-cold stop buffer (15 mM HEPES, 100 mM
glucose, 150 mM KCl, 1 mM EDTA, pH 7.0) [25]. Cells
were collected by filtration on glass microfiber filters (GF/
C, Whatman) and washed three times with cold stop
buffer (12 ml total wash volume). Cell-associated radioac-
tivity was determined with a gamma counter.
Total RNA isolation and cDNA synthesis
RWPE1, RWPE2, and RWPE2/ZIP1-Myc were grown for
24 hours and then treated with 0 or 75 µM ZnSO4 for 48
hours before harvesting. The total RNA was purified by a
micro total RNA purification kit (Invitrogen). The cDNA
was synthesized from 3 µg total RNA using a SuperScript
Choice system (Invitrogen).
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Quantitative RT-PCR analysis
cDNA was diluted 4-fold and 2 µL cDNA was added to a
quantitative PCR mixture containing corresponding
primer pair and a FAM-labeled TaqMan probe (Applied
Biosystems). The quantitative PCR reactions were per-
formed on a PRISM® ABI 7900HT Sequence Detection Sys-
tem (Applied Biosystems) in triplicate and the expression
of β-actin (ACTB) was used for normalization. Copy num-
bers for the zinc transporter genes were calculated using a
standard curve method and normalized to the copy num-
bers of ACTB.
Generation of standard curves
The amplicons generated with Assays-on-Demand primer
sets for ACTB, ZIP1, ZIP3, and ZNT1 (Applied Biosys-
tems) were inserted into the cloning vector pCR2.1-TOPO
following the manufacturer's protocol (Invitrogen). The
identity of all plasmids was confirmed by sequencing.
Plasmids were then linearized by either EcoRI or XhoI
restriction enzyme digestion before making a series of ten-
fold dilutions (103 to 108) for establishing standard curves
for mRNA quantification.
Antibodies
A chicken anti-ZIP1 and a rabbit anti-ZIP3 antibodies
were kindly given by Dr. Shannon Kelleher (Department
of Nutrition, University of California at Davis) [40]. A
mouse anti-GRP78 was obtained from Transduction Lab-
oratories. Mouse anti-Myc and anit-LAMP1 monoclonal
antibodies were purchased from StressGen. Alexa 488-
conjugated goat anti-chicken, anti-rabbit, and anti-mouse
antibodies were purchased from Molecular Probes. Perox-
idase-conjugated goat anti-mouse, anti-chicken, and anti-
rabbit antibodies were purchased from PIERCE.
Immunofluorescence microscopy
Immunofluorescence analysis was performed as described
[22]. RWPE1, RWPE2, and RWPE2 expressing vector con-
trol or the ZIP1-Myc fusion protein were cultured in slide
chambers for 48 hours, fixed with 4% paraformaldehyde,
and permeablized with 0.4% saponin (Sigma). RWPE1
and RWPE2 cells were stained with an anti-ZIP1 or an
anti-ZIP3 antibody (1:100 dilution) followed by an Alexa
488-conjugated goat anti-chicken or anti-rabbit antibody
(1:500 dilution). In the co-localization assay, RWPE2
were stained anti-ZIP3 (1:100 dilution) and anti-LAMP1
(1:50 dilution) antibodies followed by Alexa 488-conju-
gated goat anti-rabbit (1:500 dilution) and Alexa 594-
conjugaged goat anti-mouse antibodies (1:500 dilution).
RWPE2 cells expressing vector or ZIP1-Myc were stained
with an anti-Myc antibody (1:250 dilution) followed by
an Alexa 488-conjugated goat anti-mouse antibody
(1:500 dilution). Photomicrographs were obtained by a
Nikon Eclipse 800 microscope with a digital camera.
Western blot analysis
RWPE1 and RWPE2 cells were cultured in a Keratinocyte-
Serum Free medium supplemented with 5 ng/ml human
recombinant EGF and 0.05 mg/ml bovine pituitary extract
(Invitrogen) at 37°C for 48 hours. For zinc treatment,
RWPE1 cells were cultured in the medium described
above at 37°C for 24 hours. The cells were then cultured
in the medium containing 0, 25, or 50 µM ZnSO4 for
another 24 hours at 37°C. Cells were harvested and cell
lysate was prepared as previously described [22]. 50 µg
protein extracts were separated on a 4–20% Tris-HCl gel
(Bio-Rad) and transferred to a nitrocellulose membrane
(Bio-Rad). The ZIP1 and GRP78 proteins were detected by
a chicken anti-ZIP1 antibody (1:5,000 dilution) and a
mouse anti-GRP78 (1:6,000 dilution), respectively, fol-
lowed by a peroxidase-conjugated secondary antibody
(1:2,500-10,000 dilution) (PIERCE). ZIP1 and GRP78
were visualized by using an ECL kit (Amersham Bio-
sciences) and an Alpha Innotech Gel Documentation Sys-
tem (Alpha Innotech).
Cell growth
RWPE2/ZIP1-Myc and RWPE2/vector cells were plated in
12-well plates at a density of 20,000 cells/well in tripli-
cate. Zinc treatment (25 µM ZnSO4) started at day 2 after
plating. Medium was changed every 3 days. Cells were
washed twice with the culture medium to remove dead
cells and harvested by typsinization at days 6, 9, and 12
after plating. The cell suspension homogeneity was con-
firmed under microscope after trypsinization and resus-
pension. In addition, the percentages of viable cells in
these suspensions were assessed by trypan blue exclusion.
Finally, cell numbers were determined by measuring the
cell suspensions at OD600 using a standard curve for
RWPE2. The standard curve for RWPE2 cells was estab-
lished by counting cells using a hemacytometer and meas-
uring the absorptions at OD600 after typsinization and
resuspension.
Cell cycle analysis
Vector or ZIP1-Myc expressing RWPE2 were plated and
grown for 24 hours. Cells were then harvested and
counted. 2 × 106 cells were ethanol fixed and processed for
DNA staining with propidium Iodine as described [41].
Cells were run on a FACS SCAN (BD Dickenson) with a
488 nm argon laser light source. 10,000 events were
counted per sample.
Caspase 3 activity analysis
2 × 106 vector or ZIP1-Myc expressing RWPE2 were plated
in 100 mm plates and grown for 24 hours. Cells were then
treated with TRAIL (10 ng/ml) at 37°C for 6 hours. After
treatment, cells were harvested by trypsinization and sus-
pended cells were collected by centrifugation. Cells were
then processed for Caspase 3 activity assay using an Apo-
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Alert Caspase Colorimetric Assay Kit (Clontech). Caspase
3 activity was determined colorimetricly at 405 nm
according to the manufacture's instructions.
Statistical analysis
The significance of differences between sample groups
was calculated using a paired Student's t-test with a two-
tailed distribution. Differences were considered signifi-
cant at p < 0.05. Data are means ± SE or SD.
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